Hedge Fund - Highbridge Capital Management
Bridgebio Pharma Inc. (BBIO) BOND
Holding History Records
No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
---|---|---|---|---|---|
1 | 2024 - Q1 (2024-03-31) | $0 | 0% | 0 | $34.01 |
2 | 2023 - Q4 (2023-12-31) | $3,020,450 | 0.12% | 2,500,000 | $30.03 |
3 | 2023 - Q3 (2023-09-30) | $21,039,375 | 0.87% | 21,875,000 | $28.38 |
4 | 2023 - Q2 (2023-06-30) | $5,882,850 | 0.25% | 7,500,000 | $15.05 |
5 | 2023 - Q1 (2023-03-31) | $22,670 | 0.83% | 30,329,000 | $11.66 |
6 | 2022 - Q4 (2022-12-31) | $18,813 | 0.51% | 47,329,000 | $9.57 |
7 | 2022 - Q3 (2022-09-30) | $27,183,000 | 0.38% | 46,229,000 | $10.39 |
8 | 2022 - Q2 (2022-06-30) | $24,197,000 | 0.55% | 46,229,000 | $8.36 |
9 | 2022 - Q1 (2022-03-31) | $28,932,000 | 0.67% | 49,229,000 | $10.26 |
10 | 2021 - Q4 (2021-12-31) | $14,657,000 | 0.32% | 23,229,000 | $42.31 |
11 | 2021 - Q3 (2021-09-30) | $29,010,000 | 0.76% | 21,000,000 | $53.60 |
12 | 2021 - Q2 (2021-06-30) | $81,551,000 | 2.26% | 49,655,000 | $57.11 |
13 | 2021 - Q1 (2021-03-31) | $82,515,000 | 3.28% | 49,655,000 | $65.42 |
The displayed share prices are average quarterly stock market prices.